Cizzle Biotechnology (LON:CIZ) Trading Down 10.3% – Here’s What Happened

Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ) fell 10.3% on Friday . The stock traded as low as GBX 1.39 and last traded at GBX 1.39. 392,604 shares traded hands during mid-day trading, a decline of 4% from the average session volume of 409,871 shares. The stock had previously closed at GBX 1.55.

Cizzle Biotechnology Stock Down 10.3%

The firm’s fifty day moving average price is GBX 1.52 and its 200-day moving average price is GBX 1.53. The stock has a market cap of £5.51 million, a P/E ratio of -4.34 and a beta of 0.38.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.